idiopathic-pulmonary-fibrosis

Documents about idiopathic-pulmonary-fibrosis

• Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics#890256ClinicalTrials.gov
• ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis#810204ClinicalTrials.gov
• Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis#832227ClinicalTrials.gov
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study#836285ClinicalTrials.gov
• A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)#889927ClinicalTrials.gov
• Prevalence and Impact on Quality of Life of Airway Disease in Patients With Idiopathic Pulmonary Fibrosis#969665ClinicalTrials.gov
• An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)#876377ClinicalTrials.gov
• Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis#804980ClinicalTrials.gov
• Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis#153564HAL (France)
• Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis#350044ClinicalTrials.gov
• Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis#828404ClinicalTrials.gov
• Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis#872586ClinicalTrials.gov
• Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis#894146ClinicalTrials.gov
• Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis#1009976ClinicalTrials.gov
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT#377322ClinicalTrials.gov
• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients#842167ClinicalTrials.gov
• Protocol for the INterstitial lung Disease EXacerbations (INDEX) Study: a retrospective multicentre cohort study.#451388Apollo
• Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough#860426ClinicalTrials.gov
• Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.#874144ClinicalTrials.gov
• Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II#905298ClinicalTrials.gov
• Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF#800651ClinicalTrials.gov
• A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.#805635ClinicalTrials.gov
• Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)#884473ClinicalTrials.gov
• Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients#913822ClinicalTrials.gov
• Utility of bronchoalveolar lavage fluid cellular composition in the differential diagnosis of idiopathic pulmonary fibrosis: A preliminary study#414204African Journals Online
• Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis#900863ClinicalTrials.gov
• An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management#6179OpenAlex
• A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)#848950ClinicalTrials.gov
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care#889532ClinicalTrials.gov
• Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis#892892ClinicalTrials.gov
• Conducting Airways in Lung Fibrosis (VACFI)#863790ClinicalTrials.gov
• Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis#833768ClinicalTrials.gov
• Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial#811048ClinicalTrials.gov
• Is pirfenidone effective for idiopathic pulmonary fibrosis?#292970Repositorio USS
• Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole#886908ClinicalTrials.gov
• An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)#852288ClinicalTrials.gov
• Regulated Cell Death in Idiopathic Pulmonary Fibrosis.#151406NCBI PubMed Central
• Safety and Effectiveness of Nintedanib in Korean Patients#844902ClinicalTrials.gov
• Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial#829595ClinicalTrials.gov
• Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis#911793ClinicalTrials.gov
• Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis#980241ClinicalTrials.gov
• PROOF-Registry New and Extended Belgium -Luxembourg#829665ClinicalTrials.gov
• HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis#966588ClinicalTrials.gov
• Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole#842339ClinicalTrials.gov
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension#321606ClinicalTrials.gov
• Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)#981807ClinicalTrials.gov
• Immunopathologic Profiles and Blood Biomarkers in Patients With IPF#902209ClinicalTrials.gov
• A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)#827320ClinicalTrials.gov
• A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis#882508ClinicalTrials.gov
• Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.#883790ClinicalTrials.gov